Skip to main content

Table 5 Impact of subtype change and gain in receptor status on survival

From: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options

Patient Details Total Change subtype Gain of Receptor
(n = 132) (n = 31) 23.5% (n = 9) 6.8%
Survival: Months N (%) N (%) N (%)
Overall: mean (SD ±) 60 (38.3) 64.9 (40.3) 76.9 (56.3)
Post-recurrence survival: mean (SD ±) 20.7 (21.1) 18.5 (22.8) 30.6 (30.3)